Rehab CARES In USA: Clinical Trial
Rehabilitation Using Community-Based Affordable Robotic Exercise Systems (Rehab CARES)
2 other identifiers
interventional
27
1 country
2
Brief Summary
In Phase 2, Patients in a community-based setting who have had a stroke will be evaluated by rehabilitation professionals and asked to perform a battery of clinical assessments before and after standard of care and robot assisted therapy with Rehab CARES system of simple force-feedback robots that are adapted to deliver single and group therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Jun 2022
Typical duration for not_applicable stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 6, 2022
CompletedFirst Posted
Study publicly available on registry
September 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedJanuary 7, 2026
January 1, 2026
3.2 years
September 6, 2022
January 5, 2026
Conditions
Outcome Measures
Primary Outcomes (7)
Change in Motor Control
Measured by Change in Upper Extremity Fugl-Meyer Assessment (UE-FM); scale is out of 66. A lower score means more impaired.
After 12 sessions (post-pre), after follow-up at 4 weeks (post-follow-up)
Change in Gross Hand Function
Measured by Changes in Box and Block (BnB) Test; metric # of blocks transferred. A higher score means less impaired.
After 12 sessions (post-pre), after follow-up at 4 weeks (post-follow-up)
Change in Hand Dexterity
Measured by changes in NIH Toolbox 9-Hole Pegboard Dexterity Test; metric time and # of peg transferred over time. A higher number of pegs means less impaired.
After 12 sessions (post-pre), after follow-up at 4 weeks (post-follow-up)
Upper Extremity Function
Measured by changes in the Neuro-QoL: Upper Extremity Function - Fine Motor, ADL Short Form. Short form is a self-report on 8 items to assesses fine motor function and activity of daily living in upper arm.
at pre, at post-intervention (after 12 sessions), at follow-up
Quality of life (Participation)
Measured by changes in the Neuro-QoL: Ability to Participate in Social Role and Activities Short Form.
at pre, at post-intervention (after 12 sessions), at follow-up
Quality of life (Satisfaction)
Measured by changes in Neuro-QoL Satisfaction with Social Roles and Activities Short Form.
at pre, at post-intervention (after 12 sessions), at follow-up
Motivation
Measured by the Self-Assessment Manikin (SAM) scale which consist of 3 subscales: enjoyment, engagement, and control. Each subscale is from 0 to 9. For enjoyment and engagement the higher score is the better and for control the lower score is better.
at pre, at post-intervention (after 12 sessions), at follow-up
Secondary Outcomes (12)
Change in Cognition
After 12 sessions (post-pre), after follow-up at 4 weeks (post-follow-up)
Visual Spatial Attention
at pre, at post-intervention (after 12 sessions), at follow-up
Executive Function
at pre, at post-intervention (after 12 sessions), at follow-up
Active Joint Range of Motion (ROM)
at pre, at post-intervention (after 12 sessions), at follow-up
Passive Joint Range of Motion (ROM)
at pre, at post-intervention (after 12 sessions), at follow-up
- +7 more secondary outcomes
Study Arms (2)
Standard of Care
PLACEBO COMPARATOR60 min OT sessions; 3 sessions per week; for 4 weeks;-- augmented Standard therapy - consisting of PT, OT and SLP. Clinical Assessment (B1-pre, B2-post, B3-follow-up#1, B4-follow-up#2).
Robot-Assisted Therapy with Rehab CARES system
EXPERIMENTAL60 min sessions; 3 sessions per week; for 4 weeks;----of Upper Limb therapy using 1 or more affordable robots. Robot sessions can be group play and/or single play. Robot Assessment (B1-pre, B2-post, B3-follow-up#1, B4-follow-up#2)
Interventions
60 min sessions; 3 sessions per week; for 4 weeks; Patients uses 1 or more affordable robots to exercise the UL with adaptive games assessments as OT; standard of care PT and SLP; Subjects' motor and cognitive impairment will be used to set the game and modes. The game parameters will be adjusted according to motor and cognitive impairment of that station's user while the controller will automatically adjust assisting or resisting torques experienced. The 60 minutes will be broken up into 15-minute training intervals.
60 min sessions; 3 sessions per week; for 4 weeks of OT, PT, and SLP
Eligibility Criteria
You may qualify if:
- Age 55 and older (based on who is admitted to the CBR site)
- \>3 months post-stroke
- Stroke diagnosis
- Diagnosis of hemiparesis as a result of stroke (verified by radiology data)
- Motor control score on Upper Extremity Fugl-Meyer scale \> 15 and \< 60;
- Able to understand and speak
- Upper arm manual muscle strength scores \>1
- Pain Scores \< 8 based on NIH Pain Intensity Scale
You may not qualify if:
- no cerebellum lesions due to stroke
- severe cognitive function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Mercy Living Independently for Elders (L.I.F.E) - West Philadelphia
Philadelphia, Pennsylvania, 19145, United States
Penn Medicine Rittenhouse
Philadelphia, Pennsylvania, 19146, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle J Johnson, PhD
University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Alwyn Johnson, MS
Recupero Robotics LLC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2022
First Posted
September 15, 2022
Study Start
June 1, 2022
Primary Completion
August 30, 2025
Study Completion
August 30, 2025
Last Updated
January 7, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Within 2 years of project end
- Access Criteria
- Those wishing to see protocol and ICF will need to contact study PI
It is a priority of the research team to share primary data collected as a result of this project with other researchers and the National Institute of Health and associated funding agents. Findings will be disseminated within a reasonable time via newsletters sponsored by the institutions involved, peer-reviewed conference papers and journals. All journal papers will be placed on PubMed and made publically accessible. All acknowledgements will clearly define the funding agency and follow guidelines stipulated by the NIH. Copies of all publications will provided promptly. All copyright procedures will comply with the standard of NIH copyright clause. After study completion, de-identified data sets will be available to NIH and to other investigators contingent on the execution of relevant institutional data use agreements.